相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Nagma Khan et al.
BIOCHEMICAL JOURNAL (2008)
Functions of Site-Specific Histone Acetylation and Deacetylation
Mona D. Shahbazian et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2007)
Identification of a set of seven genes for the monitoring of minimal residual disease in pediatric acute myeloid leukemia
D Steinbach et al.
CLINICAL CANCER RESEARCH (2006)
AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.
S Nishida et al.
BLOOD (2006)
Acetylation of Stat1 modulates NF-κB activity
OH Krämer et al.
GENES & DEVELOPMENT (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Regulation of the INK4a/ARF locus by histone deacetylase inhibitors
A Matheu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1
N Wagner et al.
GENES & DEVELOPMENT (2005)
Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas
H Duan et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Wilms' tumour: Connecting tumorigenesis and organ development in the kidney
MN Rivera et al.
NATURE REVIEWS CANCER (2005)
Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis
IV Gregoretti et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Identification of a gene element essential for leukemia-specific expression of transgenes
N Hosen et al.
LEUKEMIA (2004)
Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
Y Oka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Activation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3
XH Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
MDM2 promotes ubiquitination and degradation of MDMX
Y Pan et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
OH Krämer et al.
EMBO JOURNAL (2003)
Post-activation turn-off of NF-κB-dependent transcription is regulated by acetylation of p65
R Kiernan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
M Göttlicher et al.
EMBO JOURNAL (2001)
Histone deacetylases and cancer: Causes and therapies
PA Marks et al.
NATURE REVIEWS CANCER (2001)
Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases
NA Barlev et al.
MOLECULAR CELL (2001)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
The murine Wilms tumor suppressor gene (wt1) locus
YL Gong et al.
GENE (2001)
Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells
G Hübinger et al.
EXPERIMENTAL HEMATOLOGY (2001)
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes
MS Kim et al.
NATURE MEDICINE (2001)
Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event
AS Weinmann et al.
NATURE IMMUNOLOGY (2001)
Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation
VM Richon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Regulation of E2F1 activity by acetylation
MA Martínez-Balbás et al.
EMBO JOURNAL (2000)
The language of covalent histone modifications
BD Strahl et al.
NATURE (2000)